Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”
Bodhisatwa Choudhuri. Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”. // International Journal of Rheumatic Diseases. – 2026. – DOI: 10.1111/1756-185x.70942. – URL: https://onlinelibrary.wiley.com/doi/10.1111/1756-185x.70942?af=R
Bodhisatwa Choudhuri (2026). Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70942
Bodhisatwa Choudhuri. “Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”.” International Journal of Rheumatic Diseases, 2026. doi:10.1111/1756-185x.70942.
@article{Choudhuri2026,
title = {Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”},
author = {Choudhuri, Bodhisatwa},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
doi = {10.1111/1756-185x.70942},
url = {https://onlinelibrary.wiley.com/doi/10.1111/1756-185x.70942?af=R}
}